Jade Biosciences, Inc. 8-K

What Happened
On May 7, 2026, Jade Biosciences, Inc. (JBIO) issued a press release announcing its financial results for the quarter ended March 31, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K under Item 2.02 (Results of Operations and Financial Condition). The filing also includes the cover page interactive XBRL file (Exhibit 104).

Key Details

• Filing date: May 7, 2026; subject: quarterly results for the period ended March 31, 2026.
• Item reported: 2.02 — Results of Operations and Financial Condition.
• Exhibit 99.1: Press release announcing the quarter’s results was furnished with the 8‑K.
• Exhibit 104: Cover page interactive data (inline XBRL) included in the filing.

Why It Matters
This 8‑K signals that Jade has publicly released its latest quarterly results — important for investors tracking earnings, revenue, cash position, and short‑term performance. The press release furnished with the 8‑K is the first formal summary of the quarter; investors should review that release and the company’s subsequent filings (e.g., quarterly report on Form 10‑Q) for detailed financial statements, metrics, and any management commentary.